Our newest portfolio stock backed off its recent 52-week high — so we’re buying more
We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade,…
We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade,…